Dr Reddy’s Laboratories has reported a consolidated net profit of Rs 960.1 crore for the fourth quarter ended March 2023. This is an increase of 890% from Rs 97 crore clocked in the corresponding quarter of last year. Its revenue from operations stood at Rs 5,843 crore in Q4 FY23, up 15.28% YoY as compared to Rs 5,068.4 crore in Q4FY22. Meanwhile, total expenses were down by 4% at Rs 5,132.2 crore against Rs 5,348.4 crore in Q4FY22.
